Gliquidone
From Self-sufficiency
Revision as of 15:48, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
File:Gliquidone.svg | |
Systematic (IUPAC) name | |
---|---|
N-(cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzenesulfonamide | |
Clinical data | |
Pregnancy category |
|
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Excretion | 95% Biliary, 5% Renal |
Identifiers | |
CAS Number | 33342-05-1 |
ATC code | A10BB08 (WHO) |
PubChem | CID 91610 |
Chemical data | |
Formula | C27H33N3O6S |
Molar mass | 527.634 g/mol[[Script error: No such module "String".]] |
(verify) |
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehriger Ingelheim, Germany.
45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from December 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Sulfonylureas
- Isoquinolines
- Imides
- Phenol ethers
- Gastrointestinal system drug stubs
- 2Fix